NCT07324629 2026-05-07Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic CarcinomaSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Phase 2 Not yet recruiting30 enrolled